Ryan White Clinics for 340B Access’ Letter to the Energy and Commerce Committee
Our nation is winning the war against the HIV/AIDS epidemic in large part because of the hard work of RWCs and the support provided by the 340B program. Our 340B…
Fighting to Preserve the Benefits of the 340B Program
Our nation is winning the war against the HIV/AIDS epidemic in large part because of the hard work of RWCs and the support provided by the 340B program. Our 340B…
We received a copy of what we believe to be the Trump Administration’s draft executive order on drug prices that would direct HRSA to scale back the 340B Program. According…
As part of President Trump’s budget released today, HRSA submitted its budget justification that includes its pledge to “work with Congress to develop a legislative proposal to improve 340B Program…
Here is a Health Reform Legislation Next Steps Memo prepared by the Powers Legislative Group on next steps for health care reform legislation. Below is the Legislative Group’s summary of…
The Senate Health, Education, Labor and Pensions (HELP) Committee will hold a hearing “in the near future” on drug spending. A bipartisan group of senators who serve on the HELP…
The Alliance for Integrity and Reform of 340B (AIR-340B) held a summit this past Tuesday focused on “reforming” the 340B program. Funded primarily by pharmaceutical companies and large oncology practices,…
The House and Senate Appropriations Committees released a bill that would maintain funding for the 340B Program at $10.24 million through September. The bill proposes to cut funding for the…
The position of Administrator of the Health Resources and Services Administration (HRSA) has been filled by Dr. George Sigounas, a professor and cancer researcher at East Carolina University Brody School…
President Trump plans to nominate Stephen Parente, a health care economist at the University of Minnesota, for the position of Assistant Secretary for Planning and Evaluation at the Department of…
A notice from Johnson & Johnson (J&J) was posted on the HRSA website stating that J&J will be issuing refunds to covered entities for overcharges on certain drugs sold between…